Evidence map›Paper›PMID 33680087›Full record

ArticleEcancermedicalscience2021

Renal liposarcoma: case report and review of systemic treatment.

Patricia Rioja, Guillermo Valencia, César Centurión-Rodriguez, Zaida Morante, Mercedes Bravo, Lourdes Huanca, Carlos Morante

Open access · goldAbstract readCase Reports
In one paragraph

Article in Ecancermedicalscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Patricia RiojaMedical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru.
Guillermo ValenciaMedical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru.
César Centurión-RodriguezMedical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru.
Zaida MoranteMedical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru.
Mercedes BravoPathology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru.
Lourdes HuancaPathology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru.
Carlos MoranteSurgical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Peru.
Instituto Nacional de Enfermedades Neoplásicas · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liposarcomas are malignant mesenchymal tumours usually located in the retroperitoneum, rarely occurring as a single lesion in the kidney. We present a case of a 59-year-old male patient with a left renal mass detected by computed tomography scan. He underwent radical nephrectomy and the histopathological study reported a primary undifferentiated liposarcoma of the kidney without nodal involvement. After 15 months of surgery, he remained asymptomatic and without evidence of disease recurrence. The objective of this report is to present a case and literature review with current evidence of treatment options and prognostic factors for survival.

Indexed as

kidney neoplasmsliposarcomanephrectomy

Identifiers

PMID33680087
PMCPMC7929774
OpenAlexW3120379109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.